- call +1-201-465-4211
- email sales@mrinsights.biz
The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.
Scope of the Report:
The worldwide market for Pediatric Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Pediatric Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs
Market Segment by Applications, can be divided into
Hospital
Clinic
Drugstore
There are 15 Chapters to deeply display the global Pediatric Drugs market.
Chapter 1, to describe Pediatric Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pediatric Drugs, with sales, revenue, and price of Pediatric Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pediatric Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pediatric Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pediatric Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pediatric Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Allergy and Respiratory Drugs
1.2.2 Anti-Infectives
1.2.3 Cancer Therapies
1.2.4 Cardiovascular Drugs
1.2.5 Central Nervous System Drugs
1.2.6 Gastrointestinal Drugs
1.2.7 Hormone Drugs
1.2.8 Urological Drugs
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drugstore
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Pediatric Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Pediatric Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Pediatric Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Pediatric Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Colgate Oral Pharmaceuticals
2.5.1 Business Overview
2.5.2 Pediatric Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
2.6.1 Business Overview
2.6.2 Pediatric Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Forest Laboratories
2.7.1 Business Overview
2.7.2 Pediatric Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Forest Laboratories Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Genentech
2.8.1 Business Overview
2.8.2 Pediatric Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Genentech Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 GlaxoSmithKline
2.9.1 Business Overview
2.9.2 Pediatric Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithKline Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Pediatric Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 MedImmune
2.11.1 Business Overview
2.11.2 Pediatric Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 MedImmune Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck
2.12.1 Business Overview
2.12.2 Pediatric Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Novartis Pharmaceuticals
2.13.1 Business Overview
2.13.2 Pediatric Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Novo Nordisk
2.14.1 Business Overview
2.14.2 Pediatric Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Novo Nordisk Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Pediatric Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pfizer Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Pharmacia
2.16.1 Business Overview
2.16.2 Pediatric Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Pharmacia Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Roche
2.17.1 Business Overview
2.17.2 Pediatric Drugs Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Roche Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Schering-Plough
2.18.1 Business Overview
2.18.2 Pediatric Drugs Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Schering-Plough Pediatric Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pediatric Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pediatric Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pediatric Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pediatric Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Pediatric Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pediatric Drugs Market Analysis by Regions
4.1 Global Pediatric Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Pediatric Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pediatric Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Pediatric Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Pediatric Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pediatric Drugs Sales and Growth Rate (2013-2018)
4.5 South America Pediatric Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pediatric Drugs Sales and Growth Rate (2013-2018)
5 North America Pediatric Drugs by Countries
5.1 North America Pediatric Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Pediatric Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pediatric Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Pediatric Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Pediatric Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Pediatric Drugs Sales and Growth Rate (2013-2018)
6 Europe Pediatric Drugs by Countries
6.1 Europe Pediatric Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Pediatric Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pediatric Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pediatric Drugs Sales and Growth Rate (2013-2018)
6.3 UK Pediatric Drugs Sales and Growth Rate (2013-2018)
6.4 France Pediatric Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Pediatric Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Pediatric Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pediatric Drugs by Countries
7.1 Asia-Pacific Pediatric Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pediatric Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pediatric Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Pediatric Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Pediatric Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Pediatric Drugs Sales and Growth Rate (2013-2018)
7.5 India Pediatric Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pediatric Drugs Sales and Growth Rate (2013-2018)
8 South America Pediatric Drugs by Countries
8.1 South America Pediatric Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Pediatric Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pediatric Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pediatric Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Pediatric Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Pediatric Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pediatric Drugs by Countries
9.1 Middle East and Africa Pediatric Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pediatric Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pediatric Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pediatric Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Pediatric Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Pediatric Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Pediatric Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Pediatric Drugs Sales and Growth Rate (2013-2018)
10 Global Pediatric Drugs Market Segment by Type
10.1 Global Pediatric Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pediatric Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Pediatric Drugs Revenue and Market Share by Type (2013-2018)
10.2 Allergy and Respiratory Drugs Sales Growth and Price
10.2.1 Global Allergy and Respiratory Drugs Sales Growth (2013-2018)
10.2.2 Global Allergy and Respiratory Drugs Price (2013-2018)
10.3 Anti-Infectives Sales Growth and Price
10.3.1 Global Anti-Infectives Sales Growth (2013-2018)
10.3.2 Global Anti-Infectives Price (2013-2018)
10.4 Cancer Therapies Sales Growth and Price
10.4.1 Global Cancer Therapies Sales Growth (2013-2018)
10.4.2 Global Cancer Therapies Price (2013-2018)
10.5 Cardiovascular Drugs Sales Growth and Price
10.5.1 Global Cardiovascular Drugs Sales Growth (2013-2018)
10.5.2 Global Cardiovascular Drugs Price (2013-2018)
10.6 Central Nervous System Drugs Sales Growth and Price
10.6.1 Global Central Nervous System Drugs Sales Growth (2013-2018)
10.6.2 Global Central Nervous System Drugs Price (2013-2018)
10.7 Gastrointestinal Drugs Sales Growth and Price
10.7.1 Global Gastrointestinal Drugs Sales Growth (2013-2018)
10.7.2 Global Gastrointestinal Drugs Price (2013-2018)
10.8 Hormone Drugs Sales Growth and Price
10.8.1 Global Hormone Drugs Sales Growth (2013-2018)
10.8.2 Global Hormone Drugs Price (2013-2018)
10.9 Urological Drugs Sales Growth and Price
10.9.1 Global Urological Drugs Sales Growth (2013-2018)
10.9.2 Global Urological Drugs Price (2013-2018)
11 Global Pediatric Drugs Market Segment by Application
11.1 Global Pediatric Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Drugstore Sales Growth (2013-2018)
12 Pediatric Drugs Market Forecast (2018-2023)
12.1 Global Pediatric Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Pediatric Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Pediatric Drugs Market Forecast (2018-2023)
12.2.2 Europe Pediatric Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pediatric Drugs Market Forecast (2018-2023)
12.2.4 South America Pediatric Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pediatric Drugs Market Forecast (2018-2023)
12.3 Pediatric Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Pediatric Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Pediatric Drugs Market Share Forecast by Type (2018-2023)
12.4 Pediatric Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Pediatric Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Pediatric Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pediatric Drugs Picture
Table Product Specifications of Pediatric Drugs
Figure Global Sales Market Share of Pediatric Drugs by Types in 2017
Table Pedia
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
